Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity

Saved in:
Bibliographic Details
Published in:EPMA Journal
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870659593536798720
collection WordPress RSS
FRELIP Feed Integration
container_title EPMA Journal
description
discipline_display Biology
discipline_facet Biology
format Online Article
RSS Article
genre Journal Article
id rss_article:102747
institution FRELIP
journal_source_facet EPMA Journal
last_indexed 2026-07-14T03:33:28.904Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity
Biology
General
Biology
sub_discipline_display General
sub_discipline_facet General
subject_display Biology
General
Biology
subject_facet Biology
General
Biology
title Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity
title_alt Terapias adyuvantes con antocianinas que potencialmente mitigan la resistencia a fármacos y los riesgos de enfermedad metastásica en cánceres de mama estratificados: la innovación conceptual de la medicina predictiva, preventiva y personalizada dirigida a la plasticidad NF-kappaB/EMT
Thérapies adjuvantes par les anthocyanes atténuant potentiellement la résistance aux médicaments et les risques de maladie métastatique dans les cancers du sein stratifiés : l'innovation conceptuelle 3PM ciblant la plasticité NF-kappaB/EMT
Terapias adjuvantes por antocianinas potencialmente mitigando riscos de resistência a medicamentos e doença metastática em cânceres de mama estratificados: a inovação conceitual 3PM direcionada à plasticidade NF-kappaB/EMT
title_auth Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity
title_es_txt Terapias adyuvantes con antocianinas que potencialmente mitigan la resistencia a fármacos y los riesgos de enfermedad metastásica en cánceres de mama estratificados: la innovación conceptual de la medicina predictiva, preventiva y personalizada dirigida a la plasticidad NF-kappaB/EMT
title_fr_txt Thérapies adjuvantes par les anthocyanes atténuant potentiellement la résistance aux médicaments et les risques de maladie métastatique dans les cancers du sein stratifiés : l'innovation conceptuelle 3PM ciblant la plasticité NF-kappaB/EMT
title_full Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity
title_fullStr Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity
title_full_unstemmed Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity
title_pt_txt Terapias adjuvantes por antocianinas potencialmente mitigando riscos de resistência a medicamentos e doença metastática em cânceres de mama estratificados: a inovação conceitual 3PM direcionada à plasticidade NF-kappaB/EMT
title_short Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity
title_sort adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3pm-conceptual innovation targeted to nf-kappab/emt plasticity
topic Biology
General
Biology
url https://link.springer.com/article/10.1007/s13167-026-00463-6